½ÃÀ庸°í¼­
»óǰÄÚµå
1595573

¼¼°èÀÇ ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Pressure Guidewires Market by Type (Flat-Tipped Pressure Guidewires, Flexible-Tipped Pressure Guidewires), Application (Coronary Artery Disease, Interventional Cardiology, Radiology), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀº 2023³â¿¡ 24¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 25¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.35%·Î ¼ºÀåÇØ 2030³â¿¡´Â 32¾ï 8,000¸¸ ´Þ·¯·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Ð·Â °¡À̵å¿ÍÀ̾î´Â ÀÎÅͺ¥¼Å³Î Ä«µð¿Ã·ÎÁö ÀýÂ÷¿¡ ÇʼöÀûÀ̸ç ÁÖ·Î °ü»ó µ¿¸Æ ÇùÂøÀ» Æò°¡ÇϱâÀ§ÇÑ ºÐȹ Ç÷·ù ¿¹ºñ·®(FFR) ÃøÁ¤À» Áö¿øÇϰí Á¤È®ÇÑ Áø´Ü Æò°¡ ¹× ÃÖÀûÈ­ µÈ Ä¡·á °èȹ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ±× Á߿伺Àº ±âÁ¸ÀÇ ¿µ»ó Áø´Üº¸´Ù Á¤È®µµ°¡ Çâ»óµÇ°í º¸´Ù Á¤È®ÇÑ ÀÎÅͺ¥¼Ç¿¡ ±â¿©ÇÏ´Â °ÍÀÔ´Ï´Ù. ¾Ð·Â °¡À̵å¿ÍÀ̾îÀÇ ÃÖÁ¾ ¿ëµµ¿¡´Â ÁÖ·Î º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ½ÉÇ÷°ü ÁúȯÀ» Àü¹®À¸·Î Çϴ Ŭ¸®´ÐÀÌ Æ÷ÇԵ˴ϴÙ. ÃÖ±ÙÀÇ µ¿Çâ¿¡¼­´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÇ »ó½Â°ú Àúħ½À ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ Å« ¼ºÀå ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. °Ç°­ °ü¸® ÀÎÇÁ¶ó °­È­, ¹«¼± ¿¬°á ¹× ¾Ð·Â º¯È¯±â ±â´É Çâ»ó°ú °°Àº ±â¼úÀû Áøº¸°¡ ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ½ÅÈï±¹¿¡¼­ÀÇ °Ç°­ °ü¸® ÁöÃâ Áõ°¡´Â »õ·Î¿î ½ÃÀåÀÇ ±æÀ» ¿±´Ï´Ù. ±ÔÁ¦ º¯°æ, »óȯ ¹®Á¦, °í±Þ °¡À̵å¿ÍÀ̾î¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ¼ºÀåÀÇ Å« °úÁ¦°¡µÇ¾ú½À´Ï´Ù. ½ÃÀå °ü°èÀÚ´Â ÀÌ·¯ÇÑ Á¦¾àÀ» ÇØ°áÇϰí Àú·ÅÇÑ °¡°ÝÀ¸·Î ½±°Ô ÀÔ¼öÇÒ ¼ö ÀÖµµ·Ï ºñ¿ë È¿À²ÀûÀÎ ±â¼ú°ú Àç·áÀÇ R&D ÅõÀÚ¸¦ °í·ÁÇØ¾ß ÇÕ´Ï´Ù. ´Ù¼öÀÇ ±â¼ú ¿ä±¸»çÇ×À» ¼ö¿ëÇÒ ¼ö ÀÖ´Â ´Ù¸ñÀû °¡À̵å¿ÍÀ̾ Æ÷ÇÔÇÑ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϰí, ÀÓ»ó°¡¿¡°Ô ½Ç¿ëÀûÀÎ Áö½ÄÀ» Á¦°øÇϱâ À§ÇÑ µ¥ÀÌÅÍ ºÐ¼® ÅëÇÕ¿¡ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã¼³°ú Çù·ÂÇÏ¿© ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â °Íµµ À¯¿ëÇÕ´Ï´Ù. ¼ÒÇüÈ­³ª °¨µµÀÇ Çâ»ó µî ¼¾¼­ ±â¼úÀÇ Çõ½ÅÀº ¿¬±¸ °³¹ßÀÇ ÀáÀçÀûÀÎ ºÐ¾ß°¡ µË´Ï´Ù. ½ÃÀåÀÇ Æ¯¼ºÀº ¿ì¼öÇÑ È¯ÀÚ °á°ú¿Í ÇÕ¸®È­µÈ ÀýÂ÷ È¿À²¼ºÀÇ Çʿ伺À¸·Î ÀÎÇØ ±â¼ú ÁøÈ­¿Í °æÀï °ÝÈ­¸¦ Ư¡À¸·Î ÇÏ´Â Á¡ÁøÀûÀÎ ¼ºÀåÀ» º¸¿©ÁÝ´Ï´Ù. ÀÇ·á Á¦°øÀÚ¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» °³Ã´ÇÏ°í ½ÅÈï±¹ ½ÃÀå¿¡ ÁÖ·ÂÇÏ´Â °ÍÀÌ ¹Ì·¡ ½ÃÀå ±âȸ¸¦ ¾ò´Â µ¥ ÇʼöÀûÀÏ ¼ö ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ °úÁ¦´Â Çõ½ÅÀûÀÎ Áøº¸¿Í ºñ¿ë °ü¸®ÀÇ ±ÕÇüÀ» ¸ÂÃß°í º¸±Þ°ú »ç¿ë ÆíÀǼºÀ» È®º¸ÇÏ´Â °ÍÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 24¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 25¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 32¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 4.35%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³²³à ¸ðµÎ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÇ »ó½Â
    • µð¹ÙÀ̽ºÀÇ Àü´Þ¿¡ µµ¿òÀÌ µÇ´Â ¾Ð·Â °¡À̵å¿ÍÀ̾îÀÇ »ç¿ë Áõ°¡
    • ±Þ¼º °ü»ó ÁõÈıºÀÇ À§Çè¿¡ ÀÇÇÑ ¾Ð·Â °¡À̵å¿ÍÀ̾îÀÇ Ã¤¿ë·üÀÇ ¼ºÀå
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¾Ð·Â °¡À̵å¿ÍÀ̾î Á¦Ç°°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ½¬¿î Á¢¼Ó¼º, Á÷Á¢ÀûÀÌ°í ½Å·Ú¼ºÀÌ ³ôÀº FFR ½ÅÈ£ÀÇ È¸¼ö¸¦ °áÁ¤Çϱâ À§ÇÑ ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ¼ö¿ä Áõ°¡
    • ¾Ð·Â °¡À̵å¿ÍÀ̾î Á¦Ç°ÀÇ ±â¼úÀû Áøº¸
  • ½ÃÀåÀÇ °úÁ¦
    • ¾Ð·Â °¡À̵å¿ÍÀ̾ »ç¿ëÇÏ´Â FFR ±â¼ú¿¡ ´ëÇÑ Á¦ÇÑ

Porter's Five Forces: ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. À» ¿¹ÃøÇÏ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÎµå·´°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¸íÈ®È÷ÇÏ°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ µû¶ó °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ³²³à ¸ðµÎ ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ²ÀÌ »ó½Â
      • µð¹ÙÀ̽ºÀÇ Àü´ÞÀ» Áö¿øÇϱâ À§ÇØ ¾Ð·Â °¡À̵å¿ÍÀ̾îÀÇ »ç¿ëÀ» ´Ã¸°´Ù
      • ±Þ¼º °ü ÁõÈıºÀÇ À§Çè¿¡ ÀÇÇÑ ¾Ð·Â °¡À̵å¿ÍÀ̾îÀÇ Ã¤¿ë·ü Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¾Ð·Â °¡À̵å¿ÍÀ̾î Á¦Ç°°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ±âȸ
      • ½¬¿î ¿¬°á, Á÷Á¢ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â FFR ½ÅÈ£ ȸº¹À» °áÁ¤ÇÏ´Â ¾Ð·Â °¡À̵å¿ÍÀ̾ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
      • ¾Ð·Â °¡À̵å¿ÍÀ̾î Á¦Ç°ÀÇ ±â¼úÀû Áøº¸
    • °úÁ¦
      • ¾Ð·Â °¡À̵å¿ÍÀ̾ »ç¿ëÇÏ´Â FFR ±â¼ú°ú °ü·ÃµÈ Á¦ÇÑ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå : À¯Çüº°

  • ÆÁÀÌ ÆòÆòÇÑ ¾Ð·Â °¡À̵å¿ÍÀ̾î
  • ÆÁÀÌ À¯¿¬ÇÑ ¾Ð·Â °¡À̵å¿ÍÀ̾î

Á¦7Àå ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå : ¿ëµµº°

  • °ü»óµ¿¸ÆÁúȯ
  • ÀÎÅͺ¥¼Å³Î Ä«µð¿Ã·ÎÁö
  • ¹æ»ç¼±°ú

Á¦8Àå ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä« ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾Ð·Â °¡À̵å¿ÍÀÌ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Asahi Intecc Co., Ltd.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Cavis Technologies AB
  • EPflex Feinwerktechnik GmbH
  • Koninklijke DSM NV
  • Koninklijke Philips NV
  • Medtronic PLC
  • Merit Medical Systems
  • Olympus America Inc.
  • OpSens Medical
  • SP Medical A/S
  • Stryker Corp.
  • Teleflex Incorporated
  • Terumo Corporation
  • Zurich Medical
JHS 24.11.29

The Pressure Guidewires Market was valued at USD 2.43 billion in 2023, expected to reach USD 2.54 billion in 2024, and is projected to grow at a CAGR of 4.35%, to USD 3.28 billion by 2030.

Pressure guidewires, vital for interventional cardiology procedures, predominantly assist in measuring fractional flow reserve (FFR) to evaluate coronary artery stenosis, making them essential for accurate diagnostic assessments and optimized treatment planning. Their importance lies in the enhanced accuracy they provide over traditional imaging, contributing to more precise interventions. The end-use scope of pressure guidewires primarily includes hospitals, ambulatory surgical centers, and specialty clinics focusing on cardiovascular diseases. Recent trends show a rising prevalence of cardiovascular disorders and an escalating demand for minimally invasive procedures as significant growth drivers. Enhanced healthcare infrastructure and technological advancements, such as wireless connectivity and improved pressure transducer capabilities, present key opportunities in the market. Additionally, increasing healthcare spending in emerging economies opens new market avenues. Regulatory changes, reimbursement issues, and high costs associated with advanced guidewires pose significant growth challenges. Market players should consider investing in R&D for cost-efficient technologies and materials to address these limitations, and increase affordability and accessibility. Opportunities lie in expanding product portfolios to include versatile guidewires capable of addressing multiple procedural requirements and integrating data analytics to provide actionable insights for clinicians. Collaborations with healthcare facilities to offer customized solutions can also prove beneficial. Innovations in sensor technology, such as miniaturization and enhanced sensitivity, present potential areas for research and development. The nature of the market indicates progressive growth characterized by technological evolution and increased competition, driven by the need for superior patient outcomes and streamlined procedural efficiencies. Developing strategic partnerships with healthcare providers and focusing on emerging markets may be integral to capturing future market opportunities. The overarching challenge will be balancing innovative advancements with cost management to ensure widespread adoption and usability.

KEY MARKET STATISTICS
Base Year [2023] USD 2.43 billion
Estimated Year [2024] USD 2.54 billion
Forecast Year [2030] USD 3.28 billion
CAGR (%) 4.35%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pressure Guidewires Market

The Pressure Guidewires Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in prevalence of cardiovascular diseases in both men and women
    • Increasing the use of pressure guidewires to help in the delivery of devices
    • Growth in the adoption rate for pressure guidewire due to the risk of acute coronary syndrome
  • Market Restraints
    • High cost associated with pressure guidewire products
  • Market Opportunities
    • Emerging demand for pressure guidewire for determining easy connectivity, direct and reliable FFR signal recovery
    • Technological advancements in the pressure guidewire products
  • Market Challenges
    • Restrictions related to FFR technology which employs the usage of pressure guidewire

Porter's Five Forces: A Strategic Tool for Navigating the Pressure Guidewires Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pressure Guidewires Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pressure Guidewires Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pressure Guidewires Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pressure Guidewires Market

A detailed market share analysis in the Pressure Guidewires Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pressure Guidewires Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pressure Guidewires Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pressure Guidewires Market

A strategic analysis of the Pressure Guidewires Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pressure Guidewires Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Intecc Co., Ltd., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Cavis Technologies AB, EPflex Feinwerktechnik GmbH, Koninklijke DSM N.V., Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Olympus America Inc., OpSens Medical, SP Medical A/S, Stryker Corp., Teleflex Incorporated, Terumo Corporation, and Zurich Medical.

Market Segmentation & Coverage

This research report categorizes the Pressure Guidewires Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Flat-Tipped Pressure Guidewires and Flexible-Tipped Pressure Guidewires.
  • Based on Application, market is studied across Coronary Artery Disease, Interventional Cardiology, and Radiology.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in prevalence of cardiovascular diseases in both men and women
      • 5.1.1.2. Increasing the use of pressure guidewires to help in the delivery of devices
      • 5.1.1.3. Growth in the adoption rate for pressure guidewire due to the risk of acute coronary syndrome
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with pressure guidewire products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand for pressure guidewire for determining easy connectivity, direct and reliable FFR signal recovery
      • 5.1.3.2. Technological advancements in the pressure guidewire products
    • 5.1.4. Challenges
      • 5.1.4.1. Restrictions related to FFR technology which employs the usage of pressure guidewire
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pressure Guidewires Market, by Type

  • 6.1. Introduction
  • 6.2. Flat-Tipped Pressure Guidewires
  • 6.3. Flexible-Tipped Pressure Guidewires

7. Pressure Guidewires Market, by Application

  • 7.1. Introduction
  • 7.2. Coronary Artery Disease
  • 7.3. Interventional Cardiology
  • 7.4. Radiology

8. Pressure Guidewires Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics

9. Americas Pressure Guidewires Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pressure Guidewires Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pressure Guidewires Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Asahi Intecc Co., Ltd.
  • 3. B. Braun SE
  • 4. Becton, Dickinson and Company
  • 5. Boston Scientific Corporation
  • 6. Cardinal Health
  • 7. Cavis Technologies AB
  • 8. EPflex Feinwerktechnik GmbH
  • 9. Koninklijke DSM N.V.
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic PLC
  • 12. Merit Medical Systems
  • 13. Olympus America Inc.
  • 14. OpSens Medical
  • 15. SP Medical A/S
  • 16. Stryker Corp.
  • 17. Teleflex Incorporated
  • 18. Terumo Corporation
  • 19. Zurich Medical
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦